Nuss John
CHIEF SCIENTIFIC OFFICER
Nuss John has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Mar 4, 2026.
On the most recent filing, Nuss John is listed as CHIEF SCIENTIFIC OFFICER at Ventyx Biosciences, Inc. Inside the rolling window, Nuss John reported no open-market purchases and 1 open-market sale totaling $98K in VTYX.
Companies traded
Other insiders at VTYX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$98K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Nuss John made?
Nuss John has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Nuss John trade?
Nuss John has filed SEC Form 4 disclosures for 1 company, including VTYX.
When was Nuss John's most recent SEC Form 4 filing?
Nuss John's most recent SEC Form 4 filing on Tracefour is dated Mar 4, 2026.
What is Nuss John's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Nuss John is listed as CHIEF SCIENTIFIC OFFICER.
What is Nuss John's total buy and sell value in the current window?
Inside the rolling retention window, Nuss John bought $0 and sold $98K based on SEC Form 4 filings.
What was Nuss John's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,675 VTYX shares on 2025-12-18, worth $98K, per SEC Form 4 filings.